Uncommon Therapeutics Is a Father's Bet That Rare Disease Drugs Don't Have to Take 20 Years
Noah Auerhahn's daughter was diagnosed with Rett Syndrome, a condition affecting 1 in 10,000 girls. He invested over $1 million in research, assembled a team with deep neuroscience expertise, and is now building a polytherapy strategy that could change how rare diseases get treated.